Bedaquiline reduced oxygen consumption and the ATP-production-associated Seahorse readout in MCF7 cells after 48 h at 1 or 10 µM. In hTERT-BJ1 fibroblasts, 10 µM for 48 h increased these readouts. The opposing responses limit generalization across cell types. [2]
ATP synthesis inhibition in mycobacterial membrane vesicles
Biochemical assay · Mycobacterium phlei inverted membrane vesicles (cell-free preparation) [1]
Bedaquiline inhibited ATP synthesis. CCCP, DCCD and omission of ADP served as negative controls; untreated vesicles synthesized ATP. The endpoint is biochemical ATP synthesis, not bacterial growth.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0–1 µM concentration-response; 0.1 µM in continuous trace
- Exposure duration
- 10 min mixing before substrate addition; subsequent continuous monitoring
- Method
- Luciferin/luciferase ATP synthesis assay
- Reported limits
- Final vehicle percentage and replicate/error semantics for Figure 2 are not stated in the selected caption/method; no growth MIC adopted.
Methods and source locations
Compound reported in the paper: Bedaquiline (TMC-207); Compound label in the paper: BDQ
Named active-moiety evidence only; no salt conversion, product-lot equivalence or clinical efficacy inference.
Figure 2A–C and caption; Results: Inhibition of the M. phlei ATP synthase; Methods: continuous luciferin/luciferase ATP synthesis assay
Inhibition of ATP synthesis: Luminescence-based ATP synthesis concentration-response — Figure 2B–C; Results: Inhibition of the M. phlei ATP synthase
ATP synthesis at 0.1 µM BDQ: Continuous luminescence with untreated and negative controls — Figure 2A and caption
Structural localization at the c-ring proton-binding site
Biochemical assay · Purified M. phlei ATP synthase c9 rotor ring, BDQ-bound and apo crystals [1]
The BDQ dimethylamino group occupies the ion-binding region and interacts with Glu65. Bromine anomalous density supports ligand localization. This isolated-ring structure supports target engagement, while rotor-blocking behavior is a mechanistic interpretation.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.35 mM added for cocrystallization
- Method
- X-ray crystallography with apo comparison and anomalous bromine signal
- Reported limits
- No product lot, isolated salt or analytical stereochemistry validation provided in the selected original text.
Methods and source locations
Compound reported in the paper: Bedaquiline (TMC-207); Compound label in the paper: BDQ
Named active-moiety evidence only; no salt conversion, product-lot equivalence or clinical efficacy inference.
Figure 4A–E and caption; Results: BDQ molecule specifically interacts with the c-ring; Methods: crystallization and structure determination
Ligand localization at c-ring ion-binding sites: Electron density/anomalous bromine localization and apo comparison — Figure 4C–E; Results: BDQ molecule specifically interacts with the c-ring
Metabolic response in MCF7 breast cancer cells
Cell-based study · Human MCF7 breast cancer cells, monolayer [2]
Bedaquiline reduced basal and maximal oxygen consumption and the Seahorse ATP-production-associated readout relative to DMSO controls. This metabolic measurement does not establish direct binding to a particular ATP synthase subunit.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 and 10 µM
- Exposure duration
- 48 h
- Method
- Seahorse XFe-96 extracellular flux; protein normalization
- Vehicle
- DMSO control
- Reported limits
- Final DMSO percentage not specified in the selected method. Figure 2 calls the derived readout ATP levels, while the panel says ATP production; it is not an independent absolute ATP concentration.
Methods and source locations
Compound reported in the paper: Bedaquiline (TMC-207); Compound label in the paper: Bedaquiline
Named active-moiety evidence only; no salt conversion, product-lot equivalence or clinical efficacy inference.
Figure 2A–D and caption; Results: Metabolic profiling of MCF7; Methods: Materials and Seahorse XFe-96 analysis
Basal/maximal respiration and ATP-production-associated Seahorse readout: Protein-normalized extracellular flux; quintuplicate wells, three independent experiments per Methods; caption describes three independent experiments — Figure 2A–D; Seahorse methods
Opposite metabolic response in fibroblasts
Cell-based study · Immortalized human hTERT-BJ1 fibroblasts [2]
At 10 µM, bedaquiline increased basal and maximal respiration and the ATP-production-associated Seahorse readout. These fibroblast results limit generalization of the inhibitory response observed in MCF7 cells.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 µM
- Exposure duration
- 48 h
- Method
- Seahorse XFe-96 extracellular flux; protein normalization
- Vehicle
- DMSO control
- Reported limits
- Final DMSO percentage not specified. Figure 5 caption mistakenly names MCF7 in its first sentence; Results, plot labels and section identify hTERT-BJ1. Immortalized fibroblasts do not establish clinical tolerability.
Methods and source locations
Compound reported in the paper: Bedaquiline (TMC-207); Compound label in the paper: Bedaquiline
Named active-moiety evidence only; no salt conversion, product-lot equivalence or clinical efficacy inference.
Figure 5A–D and caption; Results: Metabolic profiling of normal human fibroblasts; Methods: Materials and Seahorse analysis
Basal/maximal respiration and ATP-production-associated Seahorse readout: Protein-normalized extracellular flux; three independent experiments, quintuplicate wells per shared Methods — Figure 5A–D; Results: fibroblast metabolic profiling; Seahorse methods